Target intelligence / Profile preview

ARAF pseudogene 3 (ARAFP3)

Target
ARAFP3
Molecular classification
Other (Pseudogene)
01

Overview

ARAF pseudogene 3 (ARAFP3) is a processed pseudogene related to the ARAF gene, which encodes a member of the Raf kinase family involved in the MAPK signaling pathway[1][5][7]. ARAFP3 itself does not encode a protein and is classified as a non-functional genetic element. While pseudogenes were once regarded as "junk DNA," emerging evidence suggests some can regulate gene expression at the RNA level through mechanisms such as acting as competing endogenous RNAs (ceRNAs) that can modulate microRNA availability and, consequently, the expression of their parental or related genes[2][3][6]. However, there are no studies or data currently demonstrating that ARAFP3 is expressed or functions as a regulatory ceRNA or biomarker. It is not a therapeutic target, receptor, enzyme, or transporter, and there are no known drugs, safety concerns, or diagnostic/prognostic uses specifically attributed to ARAFP3[1][2][3][4][5][6][7][9]. There is nothing incorrect about the existence of ARAFP3 as a pseudogene, but it does not meet criteria for a molecular target or receptor. If "ARAFP3" was intended as a druggable receptor or enzyme, this would be a misunderstanding of current biological classification.

02

Mechanism of action

Not applicable (no drugs target ARAFP3; pseudogenes generally not targeted pharmacologically)

03

Biological functions

Competing endogenous RNA (ceRNA) activity (potential)post-transcriptional gene regulation (theoretical based on pseudogene literature[2][3][6][9][4])no established protein function
04

Disease associations

Other (Possible regulatory/molecular biomarker role in cancer if expressed, but no direct pathogenic function documented[2][3][4][6][9])

Beyond the preview

Go deeper on ARAF pseudogene 3 (ARAFP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARAF pseudogene 3 (ARAFP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call